Skip to main content
SpringerLink
Log in

Pharmacokinetics of linezolid in plasma and cerebrospinal fluid in patients with cerebral hemorrhage post-surgical intervention

  • Letter to the Editor
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Arabi Y, Memish ZA, Balkhy HH et al (2005) Ventriculostomy-associated infections: incidence and risk factors. Am J Infect Control 33:137–143

    Article  PubMed  Google Scholar 

  2. Marinho DS, Huf G, Ferreira BL et al (2011) The study of vancomycin use and its adverse reactions associated to patients of a Brazilian university hospital. BMC Res Notes 4:236

    Article  PubMed  PubMed Central  Google Scholar 

  3. An SY, Hwang EK, Kim JH et al (2011) Vancomycin-associated spontaneous cutaneous adverse drug reactions. Allergy Asthma Immunol Res 3:194–198

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Kessler AT, Kourtis AP (2007) Treatment of meningitis caused by methicillin-resistant Staphylococcus aureus with linezolid. Infection 35:271–274

    Article  CAS  PubMed  Google Scholar 

  5. Dutronc H, Bocquentin F, Galperine T et al (2005) Linezolid, the first oxazolidinone antibiotic. Med Mal Infect 35:427–434

    Article  CAS  PubMed  Google Scholar 

  6. Ippolito JA, Kanyo ZF, Wang D et al (2008) Crystal structure of the oxazolidinone antibiotic linezolid bound to the 50S ribosomal subunit. J Med Chem 51:3353–3356

    Article  CAS  PubMed  Google Scholar 

  7. De Vriese AS, Coster RV, Smet J et al (2006) Linezolid-induced inhibition of mitochondrial protein synthesis. Clin Infect Dis 42:1111–1117

    Article  CAS  PubMed  Google Scholar 

  8. Kloss P, Xiong L, Shinabarger DL, Mankin AS (1999) Resistance mutations in 23 S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center. J Mol Biol 294:93–101

    Article  CAS  PubMed  Google Scholar 

  9. Fu JJ, Ye XH, Chen C et al (2013) The efficacy and safety of linezolid and glycopeptides in the treatment of Staphylococcus aureus infections. PLoS One 8:e58240

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Vardakas KZ, Kioumis I, Falagas ME (2009) Association of pharmacokinetic and pharmacodynamic aspects of linezolid with infection outcome. Curr Drug Metab 10:2–12

    Article  CAS  PubMed  Google Scholar 

  11. Falagas ME, Vardakas KZ (2008) Benefit-risk assessment of linezolid for serious gram-positive bacterial infections. Drug Saf 31:753–768

    Article  CAS  PubMed  Google Scholar 

  12. Cojutti P, Maximova N, Crichiutti G et al (2015) Pharmacokinetic/pharmacodynamic evaluation of linezolid in hospitalized paediatric patients: a step toward dose optimization by means of therapeutic drug monitoring and Monte Carlo simulation. J Antimicrob Chemother 70:198–206

    Article  CAS  PubMed  Google Scholar 

  13. Luque S, Grau S, Alvarez-Lerma F et al (2014) Plasma and cerebrospinal fluid concentrations of linezolid in neurosurgical critically ill patients with proven or suspected central nervous system infections. Int J Antimicrob Agents 44:409–415

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Emergency Internal Medicine, The First Affiliated Hospital of Bengbu Medical College, Bengbu, 233004, China

    Yan Tang, Xiaohua Zhang, Guoyu Lu & Xiaofei Wu

  2. Departmen of Pharmacy, The First Affiliated Hospital of Bengbu Medical College, Bengbu, 233004, China

    Lingti Kong

  3. Department of Endocrinology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, 233004, China

    Chenchen Wu

Authors
  1. Yan Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lingti Kong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chenchen Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xiaohua Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Guoyu Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xiaofei Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xiaofei Wu.

Ethics declarations

Funding

This study was financially supported by the Research Innovation Program for College Graduates of Bengbu Medical College (Byycx1653).

Ethical approval

The protocol for the study was approved by the ethics committee of the First Affiliated Hospital of Bengbu Medical College.

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tang, Y., Kong, L., Wu, C. et al. Pharmacokinetics of linezolid in plasma and cerebrospinal fluid in patients with cerebral hemorrhage post-surgical intervention. Eur J Clin Pharmacol 73, 919–921 (2017). https://doi.org/10.1007/s00228-017-2239-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-017-2239-x

Keywords

Search

Navigation